These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7211088)

  • 1. Effects of acetylsalicylic acid on plasma glucose, free fatty acid, betahydroxybutyrate, glucagon and C-peptide responses to salbutamol in insulin-dependent diabetic subjects.
    Giugliano D; Passariello N; Torella R; Cerciello T; Varricchio M; Sgambato S
    Acta Diabetol Lat; 1981; 18(1):27-36. PubMed ID: 7211088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of acetylsalicylic acid on blood glucose, plasma FFA, glycerol, 3-hydroxybutyrate, alanine, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetics.
    Giugliano D; Luyckx AS; Lefebvre PJ
    Diabete Metab; 1980 Mar; 6(1):39-46. PubMed ID: 6989660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic and circulatory effects of oral salbutamol in the third trimester of pregnancy in diabetic and non-diabetic women.
    Wager J; Fredholm BB; Lunell NO; Persson B
    Br J Obstet Gynaecol; 1981 Apr; 88(4):352-61. PubMed ID: 6261782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of salbutamol on some metabolic and endocrine patterns of diabetic subjects.
    Torella R; Grandillo F; Giugliano D; Improta L; Varricchio M
    Pharmacol Res Commun; 1980 Oct; 12(9):909-19. PubMed ID: 7003602
    [No Abstract]   [Full Text] [Related]  

  • 5. Pulsatile glucagon has greater hyperglycaemic, lipolytic and ketogenic effects than continuous hormone delivery in man: effect of age.
    Paolisso G; Buonocore S; Gentile S; Sgambato S; Varricchio M; Scheen A; D'Onofrio F; Lefèbvre PJ
    Diabetologia; 1990 May; 33(5):272-7. PubMed ID: 2198186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immediate effect of a beta-adrenergic agonist (salbutamol) on carbohydrate and lipid metabolism during the third trimester of pregnancy.
    Lunell NO; Joelsson I; Larsson A; Persson B
    Acta Obstet Gynecol Scand; 1977; 56(5):475-8. PubMed ID: 602717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced glycemic responsiveness to epinephrine in insulin-dependent diabetes mellitus is the result of the inability to secrete insulin. Augmented insulin secretion normally limits the glycemic, but not the lipolytic or ketogenic, response to epinephrine in humans.
    Berk MA; Clutter WE; Skor D; Shah SD; Gingerich RP; Parvin CA; Cryer PE
    J Clin Invest; 1985 Jun; 75(6):1842-51. PubMed ID: 3891786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metabolic risks of salbutamol in diabetic patients. A study using somatostatin (author's transl)].
    Schlienger JL; Compagnie MJ; Dellenbach P; Stephan F
    Nouv Presse Med; 1980 Sep; 9(32):2247-51. PubMed ID: 6106923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
    Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
    Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ketosis-resistance in fibro-calculous-pancreatic-diabetes. 1. Clinical observations and endocrine-metabolic measurements during oral glucose tolerance test.
    Yajnik CS; Shelgikar KM; Naik SS; Kanitkar SV; Orskov H; Alberti KG; Hockaday TD
    Diabetes Res Clin Pract; 1992 Feb; 15(2):149-56. PubMed ID: 1563331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased hepatic glucagon responses in type 1 (insulin-dependent) diabetes mellitus.
    Orskov L; Alberti KG; Mengel A; Møller N; Pedersen O; Rasmussen O; Seefeldt T; Schmitz O
    Diabetologia; 1991 Jul; 34(7):521-6. PubMed ID: 1916058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Actions of salbutamol in late pregnancy: plasma cyclic AMP, insulin and C-peptide, carbohydrate and lipid metabolites in diabetic and non-diabetic women.
    Fredholm BB; Lunell NO; Persson B; Wager J
    Diabetologia; 1978 Apr; 14(4):235-42. PubMed ID: 205475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
    Gerich JE; Lorenzi M; Bier DM; Tsalikian E; Schneider V; Karam JH; Forsham PH
    J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The regulation of plasma ketone body concentration by counterregulatory hormones in man.
    Schade DS; Eaton RP
    Diabetes; 1977 Oct; 26(10):989-96. PubMed ID: 908465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of different plasma insulin concentrations on lipolytic and ketogenic responses to epinephrine in normal and type 1 (insulin-dependent) diabetic humans.
    Avogaro A; Valerio A; Gnudi L; Maran A; Miola M; Duner E; Marescotti C; Iori E; Tiengo A; Nosadini R
    Diabetologia; 1992 Feb; 35(2):129-38. PubMed ID: 1547916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose utilization during exercise in normal and diabetic subjects. The role of insulin.
    Krzentowski G; Pirnay F; Pallikarakis N; Luyckx AS; Lacroix M; Mosora F; Lefèbvre PJ
    Diabetes; 1981 Dec; 30(12):983-9. PubMed ID: 7030833
    [No Abstract]   [Full Text] [Related]  

  • 17. Modulation of fatty acid metabolism by glucagon in man. II. Effects in insulin-deficient diabetics.
    Schade DS; Eaton RP
    Diabetes; 1975 May; 24(5):510-5. PubMed ID: 805077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contribution of endogenous insulin secretion to the ketogenic response to glucagon in man.
    Schade DS; Eaton RP
    Diabetologia; 1975 Dec; 11(6):555-9. PubMed ID: 1205024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic alterations after a two-hour nocturnal interruption of a continuous subcutaneous insulin infusion.
    Scheen A; Castillo M; Jandrain B; Krzentowski G; Henrivaux P; Luyckx AS; Lefèbvre PJ
    Diabetes Care; 1984; 7(4):338-42. PubMed ID: 6381007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulsatile rather than continuous glucagon infusion leads to greater metabolic derangements in insulin-dependent diabetic subjects.
    Paolisso G; Sgambato S; Giunta R; Varricchio M; D'Onofrio F
    Diabete Metab; 1990; 16(1):42-7. PubMed ID: 2332096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.